3/31
04:05 pm
artv
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Neutral
Report
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
3/26
08:19 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
High
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
3/25
10:18 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its price target lowered by analysts at Cantor Fitzgerald from $23.00 to $20.00. They now have an "overweight" rating on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its price target lowered by analysts at Cantor Fitzgerald from $23.00 to $20.00. They now have an "overweight" rating on the stock.
3/25
10:18 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
3/25
08:18 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
3/24
04:05 pm
artv
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Low
Report
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
2/28
02:21 pm
artv
NK Cell Therapy Market on Track for Exponential Growth Amid Rising Pipeline Developments | DelveInsight [Yahoo! Finance]
Medium
Report
NK Cell Therapy Market on Track for Exponential Growth Amid Rising Pipeline Developments | DelveInsight [Yahoo! Finance]
2/20
04:05 pm
artv
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
Low
Report
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
1/29
04:05 pm
artv
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
Low
Report
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.